FR2937549B1 - Nanoparticules de derives beta-lactamine - Google Patents

Nanoparticules de derives beta-lactamine

Info

Publication number
FR2937549B1
FR2937549B1 FR0857355A FR0857355A FR2937549B1 FR 2937549 B1 FR2937549 B1 FR 2937549B1 FR 0857355 A FR0857355 A FR 0857355A FR 0857355 A FR0857355 A FR 0857355A FR 2937549 B1 FR2937549 B1 FR 2937549B1
Authority
FR
France
Prior art keywords
lactamine
nanoparticles
beta
derivatives
lactamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0857355A
Other languages
English (en)
Other versions
FR2937549A1 (fr
Inventor
Patrick Couvreur
Didier Desmaele
Fatima Zouhiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Paris Sud Paris 11
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0857355A priority Critical patent/FR2937549B1/fr
Priority to US13/126,756 priority patent/US20110269731A1/en
Priority to PCT/IB2009/054780 priority patent/WO2010049899A1/fr
Priority to EP09759782A priority patent/EP2355800A1/fr
Priority to CA2742650A priority patent/CA2742650A1/fr
Priority to JP2011533880A priority patent/JP2012507502A/ja
Publication of FR2937549A1 publication Critical patent/FR2937549A1/fr
Application granted granted Critical
Publication of FR2937549B1 publication Critical patent/FR2937549B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0857355A 2008-10-29 2008-10-29 Nanoparticules de derives beta-lactamine Expired - Fee Related FR2937549B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0857355A FR2937549B1 (fr) 2008-10-29 2008-10-29 Nanoparticules de derives beta-lactamine
US13/126,756 US20110269731A1 (en) 2008-10-29 2009-10-28 Nanoparticles of beta-lactam derivatives
PCT/IB2009/054780 WO2010049899A1 (fr) 2008-10-29 2009-10-28 Nanoparticules de derives beta-lactamine
EP09759782A EP2355800A1 (fr) 2008-10-29 2009-10-28 Nanoparticules de derives beta-lactamine
CA2742650A CA2742650A1 (fr) 2008-10-29 2009-10-28 Nanoparticules de derives beta-lactamine
JP2011533880A JP2012507502A (ja) 2008-10-29 2009-10-28 ベータ−ラクタム誘導体のナノ粒子

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0857355A FR2937549B1 (fr) 2008-10-29 2008-10-29 Nanoparticules de derives beta-lactamine

Publications (2)

Publication Number Publication Date
FR2937549A1 FR2937549A1 (fr) 2010-04-30
FR2937549B1 true FR2937549B1 (fr) 2011-04-01

Family

ID=40599981

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0857355A Expired - Fee Related FR2937549B1 (fr) 2008-10-29 2008-10-29 Nanoparticules de derives beta-lactamine

Country Status (6)

Country Link
US (1) US20110269731A1 (fr)
EP (1) EP2355800A1 (fr)
JP (1) JP2012507502A (fr)
CA (1) CA2742650A1 (fr)
FR (1) FR2937549B1 (fr)
WO (1) WO2010049899A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931152B1 (fr) * 2008-05-16 2010-07-30 Centre Nat Rech Scient Nouveau systeme de transfert d'acide nucleique
FR2937537A1 (fr) 2008-10-29 2010-04-30 Centre Nat Rech Scient Nanoparticules de statine
WO2010050624A1 (fr) * 2008-10-31 2010-05-06 Hitachi Koki Co., Ltd. Centrifugeuse
FR2988092B1 (fr) 2012-03-16 2014-04-25 Centre Nat Rech Scient Complexes de vitamine c, nanoparticules desdits complexes, procedes pour leur preparation, leurs compositions, leurs utilisations cosmetiques et procede de traitement cosmetique
EP2742955A1 (fr) 2012-12-12 2014-06-18 Centre National De La Recherche Scientifique Nanoparticules à base de bioconjugué de GAG
CN108290845B (zh) 2015-10-07 2021-08-03 大日本住友制药株式会社 嘧啶化合物
US11872216B2 (en) 2016-06-02 2024-01-16 Advanced Scientific Developments Pharmaceutical formulation comprising cineole and amoxicillin
FR3110427B1 (fr) 2020-05-20 2023-07-14 Laboratoires Eriger Conjugué terpenique de couplage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3657600A (en) * 1999-03-09 2000-09-28 Ganomycin Gesellschaft Fur Biomedizinische Forschung MBH Biologically active compounds of (ganoderma pfeifferi) dms 13239
AU2003302888A1 (en) * 2002-12-11 2004-06-30 Chong Kun Dang Pharmaceutical Corp. Oral formulations for poorly absorptive hydrophilic drugs
FR2874016B1 (fr) * 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse Nanoparticules de derives de la gemcitabine
FR2937537A1 (fr) * 2008-10-29 2010-04-30 Centre Nat Rech Scient Nanoparticules de statine

Also Published As

Publication number Publication date
FR2937549A1 (fr) 2010-04-30
CA2742650A1 (fr) 2010-05-06
US20110269731A1 (en) 2011-11-03
EP2355800A1 (fr) 2011-08-17
WO2010049899A1 (fr) 2010-05-06
JP2012507502A (ja) 2012-03-29

Similar Documents

Publication Publication Date Title
BRPI0906436A2 (pt) Derivados de ftalazinona
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BR112012015868A2 (pt) derivados de imidazolidinadiona
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
BRPI0914544A2 (pt) derivados de pirimidona substituídos
BRPI1013844A2 (pt) derivados de piridina-isoxazol
DK2397480T3 (da) Diazepindionderivat
DK2275414T3 (da) Cyclopentylacrylamidderivat
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
DK2318378T3 (da) Quinazolin-derivater
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
FR2937549B1 (fr) Nanoparticules de derives beta-lactamine
BRPI0906357A2 (pt) Derivados de oxazepinopirimidona arilamida substituídos
DK2387580T3 (da) Deoxyactagardinderivater
BR112012016923A2 (pt) Derivados de pirazol
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0907963A2 (pt) Derivados de indazola
FI20085693A0 (fi) Biosignaalin prosessointi

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: UNIVERSITE PARIS SUD, FR

Effective date: 20110930

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20110930

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20170630